NCSAPCB Tue, 25 May 2021 11:04:21 +0000 en-US hourly 1 NCSAPCB 32 32 The cost of housing and stagnant wages, not drugs, are the main causes of homelessness Tue, 25 May 2021 08:40:53 +0000

We have been your lifeline during the pandemic, the economic fallout, the wildfires, the protests and the elections. Support us with a tax deductible donation.

In her Voice of OC community opinion piece, 5/2/21, Lorri Galloway categorically states, “Drug abuse is the most definite cause of homelessness.” She doesn’t cite any studies to support this, and she doesn’t cite any experts on the causes of homelessness. She admits that “job loss is another cause”, but dismisses it as the main cause because “job loss is often the result of addiction”. Mental illness is mentioned, not as a cause of homelessness, but only to say that it is “often the result of long-term drug abuse”.

Apparently, in Galloway’s world, the skyrocketing cost of buying or renting housing in OC has nothing to do with the increase in the number of homeless people. In Galloway’s world, wage stagnation isn’t even mentioned in passing. Nowhere does it mention the role of domestic violence and the rejection of LGBTQ youth by their parents. This latter omission is particularly puzzling, given that she is the Executive Director of Eli Home, whose slogan is “Breaking the cycle of child abuse and domestic violence”.

In Galloway’s alternate reality, correlation implies causation. She states that currently 90% of mothers seeking refuge at Eli Home “are or have recently been drug or alcohol addicts”. She goes on to say that the incidence of homelessness and CO addiction have increased, as if this proves that the latter is causing the former. Nowhere does she recognize that addiction often follows the loss of a home.

Oddly enough, Galloway seems to contradict her own theory when she observes that homelessness is more prevalent in northern CO, while opioid addiction is more prevalent in southern CO.

All of the above notwithstanding, the most flawed and self-defeating aspect of Galloway’s worldview is the notion that more resources for addiction and mental health treatment are needed for shelters to be “really.” effective ”. Shelters are basically a dead end in OC, because we have a serious shortage of affordable housing for people looking for minimum wage jobs. We also have a serious shortage of permanent supportive housing, which includes the services (including behavioral and mental health treatments) that some people need to stay housed. Living in a shelter is bad for your health, even in the best of circumstances. During a pandemic, this can be a death sentence.

I don’t know what percentage of Eli Home clients end up in stable accommodation, or what the average length of time they are there, but no one should be subjected to living in a typical OC shelter for more than two weeks. . If accommodation is not available when someone enters a shelter, it is unlikely that it will be available when they leave. Residents of shelters are still homeless and likely will remain so.

The only truly effective approach to ending homelessness is to quickly produce housing that is accessible to all, in sufficient quantity to house everyone, including those who will lose their homes in the future. (God help us when the moratoriums on COVID-related evictions are lifted.)

I do not dispute the fact that addiction can play a role in the loss of a job or a home, or in the breakdown of a family. I support Galloway’s call for more addiction treatment programs, more drug rehab centers, and more focus on mental health issues. But rejecting the the main factors of homelessness, which are the cost of housing, stagnant wages and unemployment, and (for women) domestic violence (or in the case of men, incarceration) is blatantly irresponsible. Shelters will never solve homelessness, no matter how good their drug treatment programs are.

Thomas Fielder has been involved in homeless advocacy for over 3 years and is Director of Acquisitions for the OC People’s Homeless Task Force. He holds a master’s degree in biology and has worked in biomedical research his entire career, the last 26 years of which have been spent at UC-Irvine. He helped his wife raise 3 children in Anaheim, where they have lived for 37 years.

For another take on this problem, consider:

The opinions expressed in community opinion pieces are the property of the authors and not of Voice of OC.

Voice of OC wants to hear different points of view and voices. If you would like to weigh in on this issue or others, please send an email to

Source link

]]> 0
Travis Barker Says Surviving Plane Crash Was Like ‘Rehab’ | Entertainment Tue, 25 May 2021 07:00:00 +0000

Travis Barker described Death’s deception as his “rehab”.

The Blink-182 drummer – who survived a 2008 plane crash in which his assistant Chris Baker, security guard Charles Still and two pilots died – explained how the incident inspired him to experience a healthier life and to stop taking pain relievers.

He told Men’s Health magazine: “People always think, ‘Did you go to rehab?’ And me [say], “No, I was in a plane crash.” It was my rehab.

“Lose three of your friends and almost die?” It was my wake-up call. If I hadn’t been in an accident, I probably would never have quit.

The 45-year-old star – who is dating Kourtney Kardashian – hasn’t been on a plane since the crash, and instead travels by bus, car and boat.

However, he wants to overcome his fear one day, so he can come home to tell his children Landon Asher, 17 and 15, Alabama Luella – that he has ex-wife Shanna Moakler – that he managed to do. he.

He added: “If I do and the above angels help me in my travels and protect me, I would like to come back and [tell my children], ‘Hey, I just flew in here, then I went home. And all was well.

“I have to tell them, because I almost left them. It’s a perfect day.”

Travis explained how time and therapy helped him heal more than a decade after the incident, and he is now able to wake up for a few days without thinking about the accident.

He said, “The closer I got to that, I felt like I was closer to bad things than good things.

“I felt closer to the experience of trying to escape, [to] being in an accident and being burned, trying to take my friends on a burning plane.

“It haunted me for a long time… And as long as I was closer to it than to the good stuff, I was still thinking about it. Now it’s been so many years, it’s getting easier for me. have days when I will wake up without thinking about it. “

Source link

]]> 0
Tampa Bay opioid crisis escalates during pandemic Tue, 25 May 2021 04:02:56 +0000

Every day, three people in the Tampa Bay area die of an opioid overdose in what is described as “the epidemic within the pandemic” – the peak in opioid use associated with COVID-19.

To solve the problem, the Tampa Bay Partnership, a coalition of regional business leaders, recently launched a project to build support for businesses, nonprofits and faith groups to find solutions. Funded by the Florida Blue Foundation, the Opioid Tampa Bay Project was announced by Partnership CEO Rick Homans on May 21 at a virtual launch event featuring community and state leaders, including representatives from the office of Florida Governor Ron DeSantis.

“Opioid abuse threatens the health and economic fabric of our community,” Homans noted presenting a range of speakers that included Scott Rivkees, Florida Surgeon General and Secretary of the Florida Department of Health, Director Project Manager Jennifer Webb and Florida Senator Daryl Rouson of St Petersburg, and Pat Geraghty, CEO of Florida Blue, of Jacksonville.

Opioid Project

Founded in 2018, Project OPIOID was created in response to the raging opioid epidemic that claimed the lives of nearly 450,000 people across America in a decade. Since then, the COVID-19 pandemic has propelled the opioid crisis to new heights, creating the largest mental health and substance abuse crisis in U.S. history. In partnership with and with the support of Florida Blue and the Florida Blue Foundation, Project Opioid Tampa Bay will become one of six regional chapters in Florida.

Florida’s Opioid Crisis

Florida has long been at the forefront of the opioid crisis. It has been described as a three-wave epidemic dating back to the rise of opioid pill factories in the 1990s when the Tampa Bay area was at zero. In 2009, Florida was one of the very few states that did not have a prescription drug monitoring program and received national attention in 2010 when more than 2,000 opioid-related deaths were reported – 6 times more than the previous decade.

After years of legislative change and better enforcement, including the establishment of a monitoring program, the opioid problem first improved and then ‘returned to the streets’ with it. an increase in heroin deaths, marking the second wave of the epidemic. In recent years, the addition of a new more deadly ingredient – fentanyl – has entered the market. This cheaper black market drug, along with its synthetic equivalents, marked the third wave of the crisis.

While legislation has attempted to address the problem by strengthening penalties and allowing the use of drugs like naloxone by first responders, Homans said that “the current epidemic continues to evolve rapidly” and “has spared no aspect of our society, regardless of income level or ethnic group. ”He further explained“ that while thousands of people continue to work on the frontlines of the crisis, there has never been a coalition to educate the public and advocate for solutions that could save countless lives. That’s why we launched the Opioid Tampa Bay Project. “

The opioid crisis in Tampa Bay

Geraghty of Florida Blue noted that “the COVID-19 epidemic has been associated with increased rates of depression and anxiety, particularly among those struggling with addiction. As a result, we are seeing a heartbreaking increase in opioid-related overdoses and deaths. “

In the Tampa Bay area alone, more than 1,200 residents have died from opioid use in 2020. “Tampa Bay’s opioid rate is 51% higher than the national average,” said Geraghty, and cost the region around $ 25 billion in economic output.

Florida Surgeon General Rivkees, a practicing pediatric endocrinologist and chair of the pediatrics department at the University of Florida College of Medicine and chief medical officer at UF Health Shands Children’s Hospital, described the opioid overdose problem in the state as “an uphill battle”. a problem currently “even more serious than COVID-19 in our state”.

He pointed out that in 2020, drug overdoses in Florida emergency rooms exceeded those of 2019 each month. Some of the top 10 counties for these overdose visits were in the Tampa Bay area, including Hillsborough, Pasco and Polk counties, with Pinellas County having the highest number in the region. Currently, the state is spending $ 58 million on drug overdose prevention as part of a statewide initiative that will focus on 14 counties, including Pinellas.

Opioid Tampa Bay Project

Project Director Webb, who works for Omni Public and is a former Pinellas County State Representative, reported that national statistics now indicate that annual opioid-related deaths exceed those from HIV-AIDS and represent the 9th cause of death in the United States.

In Florida, she noted, opioid-related deaths disproportionately afflict black and Latin communities. And millennials, while making up only 25% of the population, account for 75% of opioid-related deaths. She stressed that the project “must address strategies that employ equity for these populations” and warned that “the opioid epidemic of 2021 is more virulent than the opioid epidemic of 2019.”

The Opioid project plans in the coming months to bring together a range of regional stakeholders, establish a data dashboard and develop a regional strategy to address the opioid crisis. Solutions to be addressed include medical treatment and the use of opioid overdose treatments such as Narcan (naloxone), counseling and public education.

Senator Rouson emphasized the importance of addressing the issue of the stigma often associated with opioid addiction. “This stigma will cause a person not to seek treatment,” he said, adding that “what we need to do is reduce the stigma by doing things like this, talking about it, creating more. awareness. ”

According to Webb, the goal of the Opioid Tampa Bay Project is to “dramatically reduce the rate of opioid dependence by 2025,” adding with some urgency, “Opioid-related deaths are almost entirely preventable.”

For more information visit Opioid Project and the Tampa Bay Partnership websites.

Source link

]]> 0
Kirin’s Mercian develops ready-to-drink alcohol-free sangria for young Japanese consumers Tue, 25 May 2021 02:31:00 +0000

Marketed under the new Mock Bar brand, the non-alcoholic sangria drink is composed of an extract of alcohol-free wine, fruit juice (orange, mango, pear, pineapple) and spices (cinnamon, mint).

Intended for a June launch, Mercian aims to sell 360,000 bottles (250ml / bottle) this year.

The ready-to-drink sangria will be sold in supermarkets, convenience stores and e-commerce platforms across Japan.

Mock Bar Brand Manager Yohei Nagaya said FoodNavigator-Asia: “In our customer survey, many consumers, especially the younger generation, responded that they like to drink, but want to enjoy their time without getting drunk, and that they want to drink products that make them feel special, even if they are not alcoholic,

“Among wine categories, sangria is popular among young people because they have a high level of experience and intention to drink it, and because it is luxurious and delicious due to its high juice content. of fruits.. “

Traditionally a beer and sake market, Mercian hopes its non-alcoholic sangria drink can attract young Japanese consumers in their 20s and 30s, who are also typically consumers of non-alcoholic beers and non-alcoholic cocktails.

The company plans to run promotions, including web and in-store campaigns, to increase consumer awareness, which will ultimately lead to increased purchasing power.


R&D for the Mock Bar range lasted 1.5 years, where the team produced over 100 prototypes.

It wasn’t easy to create an alcohol-free sangria with a rich fruit juice feel, but by adding wine extract and spices and herbs, we were finally able to create a mature and luxurious sangria.Nagaya said.

Source link

]]> 0
Byron Buxton of the twins nearing the start of his rehabilitation Tue, 25 May 2021 02:01:40 +0000

But ultimately, there seems to be some light at the end of the tunnel: Baldelli said on Monday that Buxton could be sent to rehab “towards the end of the week.”

Baldelli said Buxton could serve as a designated hitter first and if all goes well he could “play on the field for at least a day, if not several days, and then hopefully join us.”

Buxton, who was on the pitch with his teammates ahead of the game on Monday, said he started hitting in the cage over the weekend and it felt good. The real test for him is running, which he started doing but hasn’t progressed to the basics yet.

Although Buxton admitted that the progress is “just a little slower” than he would like, he is happy with the progress he has made and said that “just about everyone” is helping him not. not rush back.

“They tell me that enough to make sure I’m smart, not too much,” Buxton said. “It’s really good to have (the team) back and to have this positive energy to come back here and be healthy quickly.”

A struggling Twins side could certainly use Buxton, who was hitting .370 with a base percentage of .408 and a slugging percentage of .772 at the time of his injury, and it seems possible they will get him back earlier than initially. planned.

“The doctors made it worse than I thought it was going to be, I guess,” Buxton said. “For me, I know my body is recovering pretty quickly, so I knew I had that on my side. For me, it wasn’t going to be six weeks.

Four facing injuries

Luis Arraez (shoulder), Max Kepler (hamstrings), Nelson Cruz (wrist) and Jorge Polanco (ankle) were all excluded from the Twins’ starting lineup on Monday as they continue to face ailments.

Arraez injured his shoulder in a slip in Cleveland, Kepler’s hamstring strain affected his ability to run in the outfield, and neither Polanco nor Cruz have played since Thursday. Cruz was hit in the wrist with a throw that day during the team’s double in Anaheim, Calif.

The injury collection left the Twins shorthanded on the bench.

Kepler and Polanco’s injuries appear to be more serious than the other two, and Baldelli said, “I don’t really think anyone can answer this now,” when asked if they could avoid the injured list. .

“If we get to the point where the guys aren’t improving enough on a daily basis and they won’t be able to help us over the next few days, then we’ll make a decision when we get there,” Baldelli mentioned. “I don’t think we’re there yet. But when you have more than one or two guys getting pushed around like that, that also becomes a factor in the decision, too, when you’re dealing with four, five, six guys.

Polanco, who received a cortisone injection over the weekend, was testing the ankle pre-game on Monday. He took field drills and participated in stick training.

The infielder has had two surgery on his right ankle and further aggravated it earlier this month with a slip in a game against Oakland. The ankle is particularly troublesome for Polanco when he swings to the left, which resulted in a drop in production last season as he tried to play through the pain.

“We want to be sure where it is, what mechanism it feels it and how it affects it – whether it’s exactly the same as before or if it’s a little different,” Baldelli said. “And that’s what testing him and putting him through all of these things, hopefully.


Assistant strength and conditioning coach Andrea Hayden has accepted a job with the Stanford University women’s basketball team, spending her last day with the Twins on Monday. Hayden, who first joined the Twins in 2019 for a scholarship, was promoted ahead of the 2020 season and became the first female strength and conditioning coach in major league history. … Baldelli said Kenta Maeda, who is on the injured list with an adductor strain, also suffers from a slight pain in her arm, and it would be “at least a few days before we start putting a bullet back in. his hand.”

Source link

]]> 0
Woman sues corrections for drugs to treat addiction “Albuquerque Journal Tue, 25 May 2021 00:06:00 +0000

ALBUQUERQUE, NM – A woman who uses methadone to successfully fight heroin addiction is suing the New Mexico Department of Corrections to try to make sure she can continue to receive the drugs when she is transferred in jail next month to serve his sentence.

The woman, identified in the lawsuit only as SB, said she has been addicted to opioids for the past 20 years, has several friends and family who have died of overdoses and overdosed for more than one day. dozen times. For the past two years, she has taken methadone – a drug treatment for opioid use disorder that is approved by the Food and Drug Administration to suppress food cravings and treat symptoms of opioid withdrawal.

“She is working on her recovery every day,” the lawsuit says, adding that the treatment has helped her cope with the loss of her father to COVID-19 and the trauma of being raped. “Methadone and counseling are her lifeline. She wants to continue her doctor-prescribed treatment for OUD, recover and avoid illicit opioids. She wants to break the cycle of incarceration. If she needs it, she will continue this treatment for the rest of her life.

The lawsuit was filed in federal court on April 29 against Alisha Tafoya Lucero, the secretary of the state prison department and Wensceslaus Asonganyi, the agency’s health services administrator. Lawyers for the American Civil Liberties Union of New Mexico and the law firm of Ryan J. Villa allege that the correctional service will not provide medical treatment to inmates except those who are pregnant or who are are breastfeeding.

The lawsuit calls on the correctional service to provide SB with medical treatment throughout his incarceration and the court to declare that the Ministry’s denial of drugs “amounts to willful indifference to serious medical need (and) is a violation of the law. eighth amendment ban against cruel and unusual punishment. Lawyers filed an emergency motion on Monday asking for a preliminary injunction requiring corrections to provide the drugs and evidentiary hearings on the unfinished issue.

A spokesperson for the Correctional Service did not respond to questions about why prisons do not provide medical treatment.

“Although the department will not comment on the pending litigation, we are aware of the complaint,” Eric Harrison wrote in an email. “This individual is not detained by the NMCD.”

………………………………………….. …………..

The trial compares the opioid use disorder to other chronic conditions – such as diabetes and high blood pressure – that can be controlled with medication.

In a press release, lawyer Kate Lowe said the Corrections Department’s policy of refusing the drug is “cruel, discriminatory and dangerous.”

“Opioid overdose deaths in New Mexico continue to rise, and untreated OCD (opioid use disorder) contributes to the rate of recurrence of NMCD. NMCD has a constitutional, legal and moral duty to provide adequate medical care to our client, ”said Lowe.

The lawsuit alleges that since the Corrections Department does not provide methadone to most inmates, SB’s defense attorneys have requested that she be sent to the MDC first so that she can slowly withdraw from it. methadone, rather than being forced to go cold turkey when he arrives in prison. June 9. She is already in pain from gradually reducing her dose.

“Every day my dose is decreasing, I am more and more afraid that if the NMCD does not keep me on methadone while I am there, I will not be able to control my addiction,” SB said in a press release. . “I’m afraid that the cravings are too strong, that I will relapse, that I could overdose and die.”

Source link

]]> 0
NGM Bio’s NASH drug fails phase 2; focus shifts to programs in partnership with Merck Mon, 24 May 2021 21:08:05 +0000

An experimental NGM Biopharmaceuticals treatment for non-alcoholic steatohepatitis, fatty liver disease more commonly known as NASH, has lack in clinical trials, a surprising result given that an earlier mid-stage study showed statistically significant improvement in the patient on several measures of disease.

In view of the failed clinical trial, NGM said on Monday that resources that had been set aside for the late-stage development of the NASH drug, aldafermine, will now be applied to other drug candidates discovered internally in its pipeline, including mid-stage drug candidates for eye disease and cancer.

NASH is a fatty liver disease that causes scarring that damages the organ and can get worse to the point of requiring an organ transplant. The prevalence of the disease increases due to fatty and sugary diets. The lack of any FDA-approved therapy for NASH is prompting a growing number of companies to develop one. But over the past year, several biotechs have stumbled into clinical trials, and a company’s application for its drug NASH has been rejected by the FDA.

NGM Bio’s drug, aldafermine, is a technical version of Fibroblast Growth Factor 19 (FGF19), a human hormone that plays a role in bile acid control and also has an effect on lipid metabolism. and glucose. Last August, during the digital meeting of the International Liver Congress, NGM Bio presented data from phase 2 showing that his drug led to statistically significant results in fibrosis, or scarring of the liver, as well as resolution of the disease.

NGM Bio had continued its evaluation of aldafermine in a phase 2b study which enrolled 171 NASH patients with hepatic fibrosis. These patients were randomly assigned to receive one of three doses of the study drug or a placebo. The severity of NASH is measured on a scale from stage 1, which is the lowest severity, to stage 4, which is characterized by excessive fibrosis and loss of liver function. The main objective of the phase 2b study was to show improvement in liver fibrosis by more than one stage without worsening disease after 24 weeks.

Although they did not meet the primary goal of the Phase 2b study, NGM Bio executives noted that aldafermine achieved statistically significant results on secondary endpoints, including resolution of NASH. , which was observed at the highest of the three doses tested. The medium and high doses also achieved secondary goals assessing the reduction in liver fat content.

Nonetheless, aldafermin’s inability to meet the primary goal of the clinical trial’s primary goal means that the drug is now joining others left out of the development of NASH. Others include a small molecule developed as part of a partnership between Novo Nordisk and Gilead Sciences which in 2019, lack to improve fibrosis in a phase 3 study. The R&D alliance continues with clinical trials of other drugs, alone and in various combinations.

Last May, Genfit reported that its drug elafibrinor failed to beat a placebo in an advanced NASH test. The failure triggered a corporate restructuring which shifted the focus of the France-based company to another liver disorder. Genfit’s drug failure was followed by the FDA rejection of obeticholic acid, a NASH drug candidate from Intercept Pharmaceuticals.

While NGM Bio focuses on aldafermine, its only wholly-owned program, the company’s most advanced programs are NGM621, an antibody drug candidate for geographic atrophy of eye disorders, and NGM120, a potential treatment for it. metastatic pancreatic cancer and cachexia, which is the weight loss and wasting caused by cancer. Both drugs are in phase 2 testing and are covered by a partnership with Merck, according to a investor presentation.

The Merck alliance, which began in 2015, gives NGM Bio the ability to determine scientific direction and areas of therapeutic interest with input from the pharmaceutical giant. NGM Bio is responsible for preclinical and clinical development up to proof-of-concept studies in humans. Merck prepaid $ 94 million to NGM Bio and made an equity investment valued at around $ 106 million.

Merck, based in Kenilworth, New Jersey, is also contributing cash to its partner’s R&D. Until the end of 2020, the pharmaceutical giant paid NGM Bio $ 495.8 million as part of the collaboration, according to the biotech. Annual report 2020. If Merck licenses collaborative programs, it must pay $ 20 million for each.

According to NGM Bio’s first quarter financial report, the company had total assets of $ 425 million at the end of March, including $ 148.1 million in cash and cash equivalents.

Public domain image by Flickr user NIH Image Gallery

Source link

]]> 0
Limited access to pulmonary rehabilitation for many COPD patients – Consumer Health News Mon, 24 May 2021 14:19:24 +0000

MONDAY May 24, 2021 (HealthDay News) – About 60% of people with chronic obstructive pulmonary disorder (COPD) have a pulmonary rehabilitation (PR) center within a 10 mile radius, according to a study presented at the American Thoracic Society Conference international 2021, which was held virtually from May 14 to 19.

Gargya Malla, MBBS, MPH, University of Alabama at Birmingham, and colleagues describe the geographic variation in the availability of public relations centers among Medicare beneficiaries with a diagnosis of COPD. Data was included for 62,930,784 Medicare beneficiaries, 16.5% of whom had COPD.

The researchers identified 1,696 unique public relations centers in the United States. The average distance was 12.3 miles between residents and the nearest public relations center. Overall, 61.5, 73.3, 86.6, and 97.2 percent of Medicare beneficiaries had a public relations center within 10, 15, 25, and 50 miles, respectively. A quarter of beneficiaries lived in micropolitan areas or small towns or rural areas, which had on average one public relations center for every 4,300 beneficiaries with COPD. Overall, 72.8% of beneficiaries with COPD in metropolitan areas had a public relations center within 10 miles, compared to 38.2 and 17.1% in micropolitan areas and small towns / rural areas. , respectively.

The National Heart, Lung, and Blood Institute’s 2017 National Action Plan on COPD highlighted the important role of pulmonary rehabilitation in the care of patients with COPD, as well as limited access to pulmonary rehabilitation services. “Malla said in a statement. “For the first time, we were able to quantify this limited access. The most important step in improving the care of patients with COPD is to increase access to pulmonary rehabilitation, a very cost-effective treatment.”

Press release

More information

Source link

]]> 0
Drug prevention programs step up efforts to reduce substance use and addiction ahead of teenage summer pleasures Mon, 24 May 2021 11:09:00 +0000

SUMMIT COUNTY, Ohio – Counties in northeast Ohio are issuing warnings about spikes in drug overdose deaths, especially in Akron. The city has seen a 140% increase in the first four months of this year compared to the same period last year. In addition, preliminary data from the CDC shows that drug overdose deaths have reached an all-time high in the United States.

Like many training courses this year, drug and alcohol prevention programs in Northeast Ohio have had to pivot, while focusing on delivering important messages.

“There is so much effort going on right now in our school districts as well, really trying to focus on the general mental well-being of young people,” said Kimberly Patton, prevention and training coordinator at the board. administration of Summit County ADM. Addiction.

Patton says many of their programs are starting to return to work in person targeting teens, daycares and preschools.

“In Summit County, we start prevention as early as 18 months,” she says.

Studies show that when parents tell children about drugs and alcohol, there is a 50% chance of reducing addiction down the line. As teens look to the holidays and summer celebrations, ensuring they make informed decisions is a priority for many of these programs.

Laura Wagner, 14, who attends Revere High School, has just completed her first year with the Summit County Youth to Youth program. She says the group training showed her how to help her classmates and friends use social media to send fun and positive anti-drug messages.

“I have friends who just want a little support,” she says. “It was really fun being able to reach kids online even though we couldn’t see them in person.”

But the training also helped her cope with stress.

“I think a lot of us realize that it’s hard for a lot of people to do that. But drugs and alcohol are really harmful and we try to educate others on how they can be harmful and that it is certainly not worth it, ”she said.

For now, the group continues to host virtual camps. However, the program hopes to begin in-person training for new members in August. For more information, click on here.

Additional Resources:

Source link

]]> 0
Restaurants continue to push for permanent take-out alcohol Mon, 24 May 2021 09:37:00 +0000

The New York restaurant industry continues to pressure lawmakers to permanently expand take-out alcohol provisions in the state, which has proven to be a lifeline for many establishments in difficulty during the COVID-19 pandemic.

The New York Restaurant Association is set to release a new survey on Monday that found that 78% of New Yorkers support the permanent extension allowing customers to purchase alcoholic beverages with take-out or delivery orders, with similar majorities supporting the movement across the state.

“Throughout the COVID-19 pandemic, struggling restaurants have been able to increase their sales and keep the doors open thanks to the ability to sell alcoholic beverages with their orders,” said Melissa Fleischut, President and CEO of the New York State Restaurant Association. relief that was once needed at the height of the pandemic is still needed today. The restaurant industry needs stability more than ever, and by making “take out alcohol” permanent, we can encourage a strong recovery. It is popular with operators and customers. The numbers don’t lie.

Earlier this month, Gov. Andrew Cuomo extended the take-out alcohol provisions by executive order until June 5 after lawmakers failed to return the measure to the state budget last month. The restaurant owners’ association survey revealed that among those who bought an alcoholic drink to take away, 96% support the permanent extension.

The restaurant industry struggled during the COVID-19 pandemic, with the industry shedding thousands of jobs. Last week, New York City decided to ease pandemic restrictions on businesses and public gathering spaces as part of a wider reopening.

Restaurants said making the extension permanent would go hand in hand with the overall push to reopen businesses.

“The vast majority of New Yorkers agree that keeping alcohol on the go is a no-brainer,” said Scott Wexler, executive director of the Empire State Restaurant & Tavern Association.. “Everyone knows restaurants struggled during the pandemic, but most of all, we stood up and helped our communities as essential businesses and workers. Now, as we work to bring back the business we lost, it makes sense to keep the alcohol on the go that allows our customers to enjoy the restaurant experience at home until they are. feel comfortable, our employees get extra tips, and restaurant owners need all available sources of income to recover.

Source link

]]> 0